Psilocybin Therapy for Depression in Parkinson's Disease
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Joshua Woolley, MD, PhD
60 participants
Aug 19, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Single dose of psilocybin ranging from low ("microdose") to high delivered orally in two separate drug administration sessions with psychological support and monitoring.
Participants will receive either pimavanserin or placebo during their drug administration sessions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06455293